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Abstract: 
Compulsivity is associated with alterations in the structure and the function of parallel 
and interacting brain circuits involved in emotional processing (involving both the 
reward and the fear circuits), cognitive control, and motor functioning. These brain 
circuits develop during the pre-natal period and early childhood under strong genetic 
and environmental influences. In this review we bring together literature on cognitive, 
emotional, and behavioral processes in compulsivity, based mainly on studies in 
patients with obsessive-compulsive disorder and addiction. Disease symptoms 
normally change over time. Goal-directed behaviours, in response to reward or 
anxiety, often become more habitual over time. During the course of compulsive 
disorders the mental processes and repetitive behaviours themselves contribute to the 
neuroplastic changes in the involved circuits, mainly in case of chronicity. On the 
other hand, successful treatment is able to normalize altered circuit functioning or to 
induce compensatory mechanisms. We conclude that insight in the neurobiological 
characteristics of the individual symptom profile and disease course, including the 
potential targets for neuroplasticity is an unmet need to advance the field.  
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‘Compulsivity’ may be defined as the performance of repetitive, unwanted and 
functionally impairing overt or covert behaviors without adaptive function, performed 
in a habitual or stereotyped fashion, either according to rigid rules or as a means of 
avoiding perceived negative consequences (Fineberg et al. 2014). Probably the most 
known mental disorder characterized by compulsivity is the obsessive-compulsive 
disorder (OCD). But compulsivity is also a key feature in addictive disorders, 
Tourette’s syndrome, impulse control disorders in Parkinson’s disease, and the so-
called obsessive-compulsive and related disorders (OCRDs), such as trichotillomania 
and body dysmorphic disorder. Most brain imaging literature on compulsivity comes 
from studies in OCD. These studies mainly focused on alterations in the structure and 
the function of parallel and interacting brain circuits involved in emotional processing 
(involving both the reward and the fear circuits), cognitive control, and motor 
functioning. These brain circuits develop during the pre-natal period and early 
childhood and mature until adulthood. Alterations in neurodevelopment seem to 
underlie vulnerability to disease, but at the same time chronic symptomatology results 
in neuroplastic changes. Brain structure and function alter during the course of 
disease, with behaviours typically changing from mainly goal-directed to more 
habitual. This review aims to give a broad perspective on brain network hypotheses in 
OCD and other disorders characterized by compulsivity, based on brain imaging 
studies probing different aspects of compulsivity. After a ‘historical’ description of 
the brain circuits studied in compulsivity, we describe the complex influence of 
impulsivity, anxiety and cognitive control on these circuits. Subsequently, we 
summarize the literature on how brain function and structure change during 
development, disease course, and in response to treatment. The overall goal of this 
paper is not to give a complete overview of the literature but to generate new 
perspectives on potential targets for intervention, ideally taking into account the 
symptom profile and disease stage of the individual patient, irrespective of his/her 
diagnosis. 
 
The frontal-striatal circuits 
 
A convergence of neuroimaging research points to the involvement of parallel, partly 
segregated, cortico-striato-thalamo-cortical (CSTC) circuits in behavioral control 
functions involving motor, cognitive, affective and motivational processes (Alexander 
et al. 1986; Cummings et al. 1993; Groenewegen & Uylings 2000). These CSTC 
circuits involve direct and indirect pathways projecting from the specific cortical 
areas to the specific sub-regions of the striatum and thalamus with recurrent 
projections to the cortex. In the direct pathways an excitatory glutamatergic signal 
projects to the striatum, sending an inhibitory GABA-ergic signal to the internal part 
of the globus pallidus. This results in disinhibition of the thalamus and an increased 
excitatory effect on the cortex. In the indirect pathways, the striatum projects an 
inhibitory signal to the external part of the globus pallidus and the subthalamic 
nucleus, sending an excitatory signal to the internal part of the globus pallidus. The 
net effect is an increased inhibition of the thalamus and decreased excitation on the 
cortex. In this way the direct pathway functions as a self-reinforcing positive feedback 
loop and contributes to the initiation and continuation of behaviors, whereas the 
indirect pathway provides a mechanism of negative feedback which is important for 
the inhibition of behaviors and switching between behaviors. Normal human behavior 
relies on a flexible balance between initiation and inhibition of behavior and 
abnormalities within these pathways contribute to various maladaptive behaviours 
seen in mental disorders, such as OCD (Graybiel & Rauch 2000; Mataix-Cols & van 
den Heuvel 2006; Menzies et al. 2008; Milad & Rauch 2012), Tourette’s syndrome 
(Groenewegen et al. 2003), trichotillomania (Chamberlain et al. 2009), impulse 
control disorders in Parkinson’s disease (van den Heuvel et al. 2010; Vriend et al. 
2014), and addictive disorders (Everitt & Robbins 2005). 
The OCRDs share behavioral characteristics such as compulsivity. Brain 
imaging studies have been focused historically most extensively on OCD, but 
overlapping findings have been reported in OCRDs as well. Also considerable 
overlap exists with the studies in addictive disorders. Generally speaking, brain 
imaging studies in OCD show that an imbalance exists both between the direct and 
indirect pathways within specific CSTC circuits and between the parallel CSTC 
circuits involved in the various domains of behavior (see for some reviews Graybiel 
& Rauch 2000; Mataix-Cols & van den Heuvel 2006; Menzies et al. 2008; Milad & 
Rauch 2012; van den Heuvel et al. 2010). The interpretation of the brain imaging 
findings developed over time, and so also the ‘disease models’. For long, the OCD 
model proposed a disbalance between a hyper-activated ventral ‘emotional’, or 
motivational, circuit (due to dominance of direct pathway) and a hypo-activated 
dorsal ‘cognitive’ circuit (due to dominance of the indirect pathway) (Mataix-Cols & 
van den Heuvel 2006). The ventral circuit, connected with the limbic brain regions, is 
important for the appraisal of emotional significance of situations and the generation 
of emotional responses and reward-based behaviours. The dorsal circuit, with strong 
involvement of the associative cortices, is crucial for the subsequent modulation of 
the initial response, by top-down control over the ventral circuit. In this simplified 
working model of OCD the hyper-activated ventral ‘emotional’ circuit explains the 
increased anxiety and repetitive behaviours, and the hypo-activated dorsal ‘cognitive 
control’ circuit explains the cognitive control deficits and inability to modulate 
emotional and behavioural responses (Phillips et al. 2003a, 2003b).  
More recently, based on the insight that within the ventral prefrontal cortex 
important differentiation exists between affective and cognitive processes, and that 
some control processes are more ventral than the classical executive functions such as 
working memory and planning, Milad & Rauch (2012) proposed three instead of two 
important CSTC circuits for OCD: the ‘affective circuit’, the ‘ventral cognitive 
circuit’ and the ‘dorsal cognitive circuit’ (Milad & Rauch, 2012). The affective 
circuit, connecting the ventromedial prefrontal cortex and anterior cingulate cortex 
with the nucleus accumbens and the thalamus, is relevant for affective and reward 
processing. The dorsal cognitive circuit, connecting dorsolateral prefrontal cortex, the 
caudate nucleus and the thalamus, is crucial for executive functions such as working 
memory and planning. The ventral cognitive circuit, connecting anterolateral 
orbitofrontal cortex, anterior part of the putamen and thalamus, is involved in motor 
preparation and response inhibition (Milad & Rauch, 2012).  
After the initial focus of brain imaging studies on the orbitofrontal cortex and 
the ventral striatum, whole brain imaging studies (both structural and functional) 
increasingly reported the involvement of brain regions outside the frontal-striatal 
brain areas (Menzies et al. 2008). Optimal higher-order cognitive processing, for 
instance, also relies on strong fronto-parietal connections, mainly between the lateral 
prefrontal cortices and the inferior parietal lobe / sulcus. During development these 
fronto-parietal connections develop and increasingly contribute to the integration of 
multiple first-order (e.g., visuospatial, semantic, temporal) associations to reach 
higher-order associations (Wendelken et al. 2015). This so-called ‘relational thinking’ 
is necessary to learn associations among stimuli in our environment higher-order 
relational comparisons (Vendetti & Bunge 2014). 
Since the discussion on the key feature of OCD, being anxiety or 
compulsivity, and the decision to shift OCD from the anxiety disorders category to 
the obsessive-compulsive and related disorders category in the DSM-5 (APA, 2013), 
brain imaging studies in OCD increasingly focused on the compulsive aspects, using 
paradigms focusing on reward learning, response inhibition, and habit learning. Also 
trans-diagnostic comparatives studies have been initiated, although still scarce relative 
to the mono-diagnostic studies being published predominantly. This development in 
thinking about the disorders introduced the sensorimotor circuit as 4
th
 relevant CSTC 
circuit in the disease model. The associative striatum (involving mainly the caudate 
nucleus) is especially active during early stages of goal-directed behavior, but with 
extended training, it’s contribution gradually reduces (Thorn et al. 2010). The 
sensorimotor CSTC circuit, connecting the (pre)motor cortex, putamen and thalamus, 
then increasingly mediates automatic responding and the transition from goal-directed 
to habitual behaviors. This leads to an increase in stimulus-response-like habitual 
behaviors involving the sensorimotor part of the striatum (mainly the posterior part of 
the putamen) and, at a certain stage, decreased dependence on striatal dopaminergic 
projections (Ashby et al. 2010).  
 
- insert figure here - 
 
Although the parallel CTSC circuits largely are segregated, it is evident that complex 
behaviors depend on between-circuit communication since the involved sub-processes 
subserved by different CSTC circuits cannot be executed independently.  
The communication between the ‘affective’ (or motivational) circuit and the 
sensorimotor circuit is especially important for habit learning and compulsivity. 
Several ways of communication and integration between the circuits have been 
described. One mechanism of integration might be via the dopaminergic projections 
at the striatal level (Groenewegen et al. 2003). The balance between goal-directed and 
habitual behavior also depends on the top-down control processes involving the 
ventral and dorsal ‘cognitive’ circuits. In the context of human behaviors and the 
development of mental disorders, it is important to realize that adaptive and 
maladaptive behaviors ‘evolve’ during neurodevelopment across the life span and 
during the course of the disease, associated with shifts within and between the 
involved circuits. Below we discuss these transitions during the various stages of 
development and disorder and the between-circuit interactions involved. 
 
Most brain imaging studies cited in this review concern structural and functional MRI 
studies. Conventional task-related fMRI experiments primarily focus on task-related 
activation of individual brain areas. However, fMRI also allows studying activity 
within networks of brain areas and the interactions between brain areas. In this way, 
fMRI can investigate not only which specific brain areas are involved in a task, but 
also how functionally connected brain regions communicate (Stephan, 2004) and how 
this varies under different conditions. This development converted our ‘brain region’-
thinking into a more ‘brain network’-thinking. Psycho-physiological interaction (PPI) 
analyses, for example, can be used to examine how functional connectivity between 
seed regions and the rest of the brain is altered by psychological variables (i.e. task 
conditions) (Friston et al. 1997). In order to study the direction of the altered 
connectivity dynamic causal modeling (DCM) can be used (Friston et al. 2003). The 
combined analysis of fMRI (or electrophysiology) data and measures of structural 
connectivity (e.g., using diffusion tensor imaging) increases our insight in the relation 
between functional networks and the structural wiring. Recent developments in the 
quantitative analysis of complex networks, based largely on graph theory, have been 
rapidly translated to studies of brain network organization. Both anatomical 
connections in the brain
 and the communication between neurons exhibit ‘small-world 
topology’ (Bullmore & Sporns 2009; 2012), as most other networks that require for 
instance efficient communication (e.g. social media) or transport (e.g. underground). 
The Human Connectome Project is building a "network map" of the anatomical and 
functional connectivity within the healthy human brain (see the open-access database 
at http://www.humanconnectomeproject.org), and also produces a body of data that 
will facilitate future research into brain disorders. It will also contribute to our 
understanding of how brain networks evolve during normal development, how disease 
influences network functioning, and how interventions interact with it.  
 
Cognitive control, the role of the ventral and dorsal cognitive control circuits  
 
Neural correlates of compulsivity have been primarily assessed in cognitive flexibility 
tasks (e.g., probabilistic reversal learning task (O’Doherty et al. 2001)). Also, 
response inhibition paradigms (e.g., Stop Signal task (Logan 1994), Go-NoGo task 
(Donders 1969) and more general higher-order executive functions, including 
planning (e.g. Tower of London task, (Shallice 1983)) and working memory (e.g. N-
back task, (Gevins & Cutillo 1993)) seem to be relevant to explain cognitive control 
impairments in compulsive disorders. Moreover, to probe the interaction between the 
ventral and dorsal cognitive control circuits with the limbic areas, emotion regulation 
(or reappraisal) paradigms, which by definition involve executive control over 
emotions, have been developed (Ochsner et al. 2014). 
 Impaired probabilistic reversal learning in OCD is associated with 
hypofunction of bilateral orbitofrontal and parietal cortices, both in patients with 
OCD and unaffected relatives (Chamberlain et al. 2008). Similarly, Remijnse et al. 
(2013) showed decreased lateral orbitofrontal activation in OCD during probabilistic 
reversal learning, accompanied by increased putamen and anterior cingulate 
activation. Other authors have shown that perceptual shifting is more associated with 
engagement of the parietal cortex (Ravizza and Carter 2008). Remijnse et al. (2006) 
also showed decreased activation in the more dorsal parts of the prefrontal cortex 
during probabilistic reversal learning in OCD patients. A human lesion study, 
however, showed that the dorsolateral prefrontal cortex plays a more general role in 
executive functioning (including attention) and not reward-related reversal learning 
per se, while lesions of the orbitofrontal cortex (only in case of bilateral lesions) result 
in clear impairments in probabilistic reversal learning (Hornak et al. 2004). Task 
switching, conversely, is associated with engagement of the dorsal parts of the 
prefrontal cortex (Ravizza and Carter 2008). This is consistent with the proposition of 
Milad et al. (2012) to differentiate between the ventral and dorsal ‘cognitive control’ 
circuits. Also here there is no strict segregation between these dorsal and ventral 
circuits and many cognitive paradigms used in fMRI studies involve a combination of 
multiple cognitive processes related to partly segregated and partly overlapping neural 
circuits.  
Response inhibition can be considered an operationalization of certain aspects 
of both impulsivity and compulsivity (Bari & Robbins 2013). Response inhibition 
largely depends on a proper function of the inhibition network, which is mainly right 
lateralized, with the inferior frontal cortex and pre-supplementary motor area (pre-
SMA) as key components of the network. From here the stop signal goes to the motor 
cortex through CSTC projections, also involving parietal regions, anterior insula, 
cingulate cortex and the dorsolateral prefrontal cortex (Chambers et al. 2009; 
Sebastian et al. 2013a). For an extended review on the neural correlates of motor 
response inhibition and interference in obsessive-compulsive spectrum disorders, see 
van Velzen (2014), summarizing the results of fMRI studies on interference control 
(Flancker task, Simon task, Stroop task), action restraint (Go-NoGo task) and action 
cancellation (Stop Signal task) in OCD, ADHD, Tourette’s syndrome, and 
trichotillomania. Based on this overview, it can be concluded that patients within the 
impulsive-compulsive spectrum, both the hyperdopaminergic disorders (e.g. OCD, 
Tourette, trichotillomania) and the hypodopaminergic disorders (e.g., ADHD, 
Parkinson’s disease), exhibit the same deficits in response inhibition due to altered 
recruitment of the inhibition network. The behavioral and neural deficits are also 
present in unaffected siblings of the patients (Chamberlain et al. 2007, Menzies et al. 
2007; de Wit et al. 2012). Whether these inhibition-related brain areas are hypo- or 
hyperactivated depends on the complexity of the paradigm and the ability to 
compensate. As an example, the Stop Signal task exerts higher demands on subjects, 
and thus puts higher strain on the compensational resources of the inhibition network, 
compared to the Go-NoGo task (Sebastian et al. 2013b), and is thus more sensitive to 
detect inhibition impairments in patients. The altered recruitment of the dorsal 
cognitive control system in OCD and related disorders, related to impaired response 
inhibition, and other relevant executive functions such as cognitive flexibility, 
planning and working memory, seems to be at least partly related to altered 
connectivity with the limbic regions (van den Heuvel et al. 2011; de Vries et al. 2014; 
van Velzen et al. 2014, van Velzen et al. 2015).  
The interaction between cognitive control circuits and the limbic areas is 
specifically relevant for emotion regulation. The ability to manage emotional 
information is central to our daily functioning (Ochsner et al. 2002; Ochsner & Gross 
2005). When emotion regulation, i.e., the process of moderating the emotional impact 
of a certain thought or stimulus through cognitive reinterpretation (Gross 2013), is 
impaired the individual is at risk to develop mental diseases, including mood (Erk et 
al. 2010), anxiety (Ball et al. 2012), addictive (Fox et al. 2007), and obsessive-
compulsive disorders (Jacobs et al. 2012). A recent fMRI study in cocaine-dependent 
individuals revealed that impaired emotion regulation was related to decreased 
activation in brain areas related to emotion regulation and decreased functional 
connectivity between prefrontal cortex and the amygdala during reappraisal of 
negative emotions (Albein-Urios et al. 2014). Impaired recruitment of the dorsal 
prefrontal areas and altered limbic responding during effortful emotion regulation is 
also found in OCD (de Wit et al. 2015) and unipolar and bipolar depression (Rive et 
al. 2015), suggesting that it is a more general feature in most mental disorders. 
However, although not specifically related to compulsivity, impaired emotion 
regulation, accompanied by increased limbic activation and decreased dorsal 
cognitive control activation, contributes to maladaptive behaviors, including habits. 
As an example of this, Goodwin et al. (2014) recently showed in a longitudinal 
follow-up study in 572 adolescents that compulsive exercise was predicted by 
dysfunctional emotion regulation strategies. 
 
From impulsivity to compulsivity, shift from ventral to dorsal CSTC 
 
The CSTC loops are less segregated than initially thought. Anatomical evidence 
suggests a more integrated system, with information cascading from one loop to the 
next (Haber & Knutson 2010). In literature, there is a common belief, particularly 
based on animal research, that gradually over time a specific functional shift occurs 
from impulsivity to compulsivity, and from goal-directed to habitual behavior, 
associated with a specific anatomical shift. 
Impulsivity is a risk factor for the development of addictive disorders (Slutske 
et al. 2012) and relapse after remission (Stevens et al. 2014; Verdejo-García et al. 
2008). In a rat model of cocaine addiction, high impulsivity predicts the development 
of addiction-like behaviors in rats, including persistent or compulsive drug taking in 
the face of aversive outcomes (Belin et al. 2008).  
As described above, the striatum is a key structure in modulating behavioral 
responses that are under the control of both action-outcome and stimulus-response 
mechanisms, by incentive motivational processes and Pavlovian associations, 
respectively. Most evidence for this impulsive to compulsive shift comes from classic 
animal studies on addiction, suggesting a shift from ventral to more dorsal domains of 
the striatum in animals with compulsive drug use, i.e. continuing use despite adverse 
consequences (Everitt & Robbins, 2005). During the development of addictive 
behaviours the initial dopamine-dependent, striato-nigro-striatal ascending routes 
from the nucleus accumbens, underlying action-outcome mechanisms under the 
influence of protracted exposure to addictive drugs, shift to recruitment of more 
dorsal and posterior regions of the striatum, mainly the putamen, underlying stimulus-
response mechanisms in the control over drug seeking behaviors (Belin et al. 2009). 
However, based on recent findings by Murray et al. (2014), impulsivity per se does 
not seem to be the facilitating factor in this ventral-to-dorsal intra-striatal shift. 
Studying the effects of dopamine blockage in the dorsolateral striatum of rats (using 
bilateral infusions of the dopamine receptor antagonist -flupenthixol) on cocaine 
seeking behavior at different stages of training, they found a delayed shift from 
ventral to dorsal striatal dopaminergic control over cocaine use in high-impulsive rats 
compared to low-impulsive rats (Murray et al., 2014). This suggests that although 
impulsivity has been identified as a key marker of the individual propensity to swift 
from controlled to compulsive drug use (Belin et al. 2008) and is characterized by low 
ventral striatal dopamine receptor availability (Dalley et al. 2007), it does not simply 
facilitate the ventral-to-dorsal shift at the neuronal level. One might explain these 
findings by the interacting cortico-striatal processes related to impaired response 
inhibition and cognitive flexibility, contributing to decreased cognitive control over 
maladaptive inflexible behaviors.  
Computational models supported this idea (Piray et al. 2010; Egbert & 
Barandiaran 2014). Egbert and Barandiaran (2014), for example, recently developed 
an elegant dynamic computational sensorimotor model for the study of habits that, 
unlike the traditional stimulus-response-probabilities based models, assumes a more 
dynamic transition and interaction between stimulus-response and action-outcome 
forms of behaviours, involving simultaneous activation in multiple CSTC circuits. 
The model is based on the assumption that habits are self-maintaining patterns of 
behaviour in a complex ecological context, where trajectories taken through the 
sensorimotor space increase the likelihood that in the future similar trajectories will 
be taken, under influence of reinforcing and inhibiting parallel processes. 
 
Unlike the large body of literature on compulsivity in animals, human studies 
supporting the ventral-to-dorsal shift are rare. A functional MRI (fMRI) study in 
heavy drinkers versus social drinkers showed decreased cue reactivity in the ventral 
striatum in heavy drinkers compared to social drinkers, suggesting that the shift from 
ventral to dorsal striatal reactivity takes place relatively early (Vollstadt-Klein et al., 
2010). Another fMRI study, with a more severe group of alcohol-dependent patients 
(mean duration 15 years alcohol dependence) showed over-reliance on habit learning 
in alcohol-dependent patients accompanied by an increased recruitment of posterior 
putamen and a decreased recruitment of the anterior putamen and ventromedial 
prefrontal cortex (Sjoerds et al. 2013). This fits with the finding that longer duration 
of alcohol dependence is associated with lower activity of the ventromedial prefrontal 
cortex, suggestive of increasingly diminished ventral route involvement with 
development of chronicity. Alcohol-dependent patients, compared with healthy 
controls, are more prone to develop habitual response patterns in context of possible 
wins, reflected in stronger posterior caudate and putamen activity during a gambling 
task (van Holst et al. 2014). In a recent fMRI study on habit formation in OCD 
patients, Gillan et al. (2015) tested, using a shock avoidance paradigm, whether habits 
in OCD primarily arise from dysfunction in the goal-directed (ventral) or the habit 
(dorsal) system. Excessive habit formation in OCD patients was associated with 
hyperactivation of the caudate nucleus, not the putamen. Although the authors 
interpret the findings as supportive for a failure in the goal-directed system, one might 
also explain the hyperactivation of the caudate nucleus during habit formation as a 
compensatory mechanism in the dorsal cognitive control system. This fits with the 
findings of other fMRI studies on cognitive control in OCD, showing compensatory 
hyperactivation of the executive network during response inhibition (de Wit et al. 
2012) as well as working memory (de Vries et al. 2014) in both OCD patients and 
their unaffected siblings.  
 
In short, although there is some evidence for a ventral-to-dorsal shift underlying the 
development of compulsive behaviours, the findings are not yet conclusive and more 
complex interactions between related circuits seem to be involved as well, such as a 
failure of the dorsal executive control system as well as the interference from the 
limbic system. Functional connectivity studies can contribute to a better insight on 
these complex within and between-network interactions.  
 
From anxiety to compulsivity, the role of the limbic circuit  
 
The majority of studies that investigated the neural basis of compulsivity have 
focused on the cortico-striatal network. Although repetitive behavior is at the core of 
compulsive disorders, anxiety and distress are important symptoms in many OCRDs 
as well. OCD was classified as anxiety disorder in the previous versions of the DSM 
and shares many behavioral and neural characteristics with other anxiety disorders, 
such as harm avoidance, feelings of uncertainty, hyper-responsiveness of the limbic 
system, and impaired cognitive control on emotion. Also trichotillomania and skin-
picking disorder often cause significant distress, and a negative emotional state 
(including anxiety) is part of the withdrawal symptoms in drug addiction. Whereas 
repetitive actions are particularly associated with the cortico-striatal network, negative 
affect is typically associated with increased activity in the limbic circuit. Although the 
limbic circuit is ill defined, it is considered to consist of subcortical structures such as 
the amygdala, hippocampus, anterior thalamus, fornix, mammillary bodies, as well as 
the cingulate gyrus (MacLean 1949). All these brain structures potentially have a role 
in compulsivity, but the amygdala may be of particular interest because of its well-
established role in anxiety and its strong integration within the cortico-striatal system 
(Cho et al. 2013). It is crucial for the detection of salient events, and can initiate a 
cascade of psychological and physiological processes that lead to an anxious state 
(Davis & Whalen 2001; Ulrich-Lai & Herman 2009). As such, it may be optimally 
situated to guide behavior when faced with aversive as well as appetitive stimuli 
(Cardinal et a. 2002; Balleine 2005).  
Due to its clear relatedness to other anxiety disorders, the involvement of the 
limbic system in compulsivity is most often investigated in OCD. Initial studies that 
have investigated limbic functioning in this disorder have used techniques to measure 
blood flow or glucose metabolism at rest. A meta-analysis reported consistent 
differences in neural activity in the orbitofrontal cortex and caudate nucleus, but 
found no consistent evidence for differences in other brain regions (Whiteside et al. 
2004). Later studies noted that the limbic regions come into play when obsessive-
compulsive symptoms are induced by confronting patients with their feared stimuli 
(Breiter et al. 1996). A meta-analysis of these so-called symptom provocation studies 
showed consistent activation in multiple regions in the prefrontal cortex including the 
anterior cingulate cortex, precuneus, superior temporal gyrus, insula, caudate nucleus, 
posterior cingulate cortex, and superior parietal lobule. No consistent amygdala 
activation was reported, even though increased activation in close proximity of the 
amygdala in the hippocampus and uncus was demonstrated (Rotge et al. 2008). 
However, several studies that were not included in the meta-analysis have reported 
amygdala activation, suggesting that the experience of obsessive-compulsive 
symptoms is also associated with amygdala activation (Adler et al. 2000; van den 
Heuvel et al. 2004; van den Heuvel et al. 2005; Simon et al. 2010; Simon et al. 2014; 
de Wit et al. under review). Yet other studies have investigated whether the amygdala 
is also more responsive to more general emotional stimuli, not directly related to 
OCD symptoms, which is often the case in other anxiety disorders (Etkin et al. 2007). 
Initial studies suggested that amygdala reactivity to emotional faces was actually 
reduced (Britton et al. 2010; Cannistraro et al. 2004), which suggested that OCD may 
be different from other anxiety disorders by lacking generalized amygdala 
hypervigilance. However, more recent studies do suggest increased amygdala 
reactivity to emotional face stimuli as well (Cardoner et al. 2011; Via et al. 2014). 
These apparent opposite results could in part be explained by methodological 
differences, such as implicit versus explicit emotion perception and active versus 
passive task performance. The later studies also showed increased activity in a 
widespread network of brain regions outside the amygdala, including the fronto-
parietal network, orbitofrontal cortex, thalamus, and insula (Cardoner et al. 2011; Via 
et al. 2014). Together, these studies suggest that activity in the limbic system is not 
particularly altered during rest, but that it is more responsive to emotional stimuli and 
recruited during the experience of OCD symptoms. 
To investigate the integration of the limbic system with the cortico-striatal 
network, more recent studies have used functional connectivity analyses by analyzing 
the correlation between time-courses in these brain regions, which is thought to reflect 
the level of functional interaction. Such studies reported increased amygdala 
connectivity with the fronto-parietal network during emotional face processing, 
(Cardoner et al. 2011), working memory performance (de Vries et al. 2014), and 
response inhibition (van Velzen et al., 2015). Conversely, reduced amygdala 
connectivity with the anterior cingulate and orbitofrontal cortices during a risky 
choice game or with the nucleus accumbens during the anticipation of gains and 
losses has been reported (Admon et al. 2012; Jung et al. 2013). Recent studies have 
also investigated connectivity of the cortico-striatal network with the limbic network 
during rest, and have predominantly found reduced functional connectivity between 
these networks, which may in part be related to aggressive symptoms (Jung et al. 
2013; Harrison et al. 2013; Gottlich et al. 2014). These studies suggest that the 
interaction between the limbic and cortico-striatal networks is altered in OCD. 
Connectivity can be enhanced as well as reduced, which may be dependent on the 
state of the patient.  
Limbic network activity and its integration with the cortico-striatal network 
has mainly been investigated in OCD, but similar differences in limbic-cortico-striatal 
network connectivity have been reported in addiction (Ma et al. 2010) as well as 
trichotillomania (White et al. 2013). These mechanisms may therefore also be 
involved in other disorders characterized by compulsivity, but needs to be 
investigated in future studies. 
 
Neurodevelopment and neuroplasticity 
 
The brain is in continuous development and adaptation, under influence of genetic, 
behavioral and environmental factors. Neuroplastic changes occur due to normal age-
related changes during life span (involving both neurodevelopmental and 
neurodegenerative processes), due to presence of chronic and often recurrent 
symptoms of compulsivity, and under influence of therapeutic interventions. 
Nevertheless, since most imaging results in psychiatry (including OCD, addiction and 
related disorders) are based on cross-sectional studies in mostly adult patients, strong 
conclusions on the neuroplastic changes during the various stages of development and 
disease are difficult to make. 
During normal development, processes relevant for cognitive control are 
assumed to shift from initial ventral areas during early childhood to more dorsal 
regions during adolescence and adulthood, by gradual maturation of the dorsal circuit 
(Perlman & Pelphrey 2010, 2011; Gogtay et al. 2004). One might hypothesize that a 
‘dorsal-ventral imbalance’ due to altered brain development (early in life), may 
hamper cognitive control and increase the vulnerability to neuropsychiatric disorders 
such as compulsive disorders. CSTC circuits develop from infancy to adolescence 
(Colibazzi et al. 2008). Since the dorsal cognitive CSTC circuit matures only 
relatively late during adolescence, which continues into early adulthood (Arnsten & 
Rubia 2012), individuals seem to be more vulnerable to the development of 
compulsive behaviors during this developmental stage. Children with compulsive 
disorders show alterations in, at least partly, similar brain circuits as adults. There are, 
however, also differences, related to the onset of disease and the development of 
specific CSTC circuits. Children with OCD, for instance, display more neurological 
signs than adults with OCD, such as tics or choreiform movements, which suggests a 
greater involvement of the sensorimotor CSTC circuit (Geller et al. 1996). Montigny 
et al. (2013) observed that in a very large sample of 1938 adolescents, compulsive 
behavior was associated with increased right striatum volume (similar to what is 
observed in adults), but also with increased gray matter volume in right dorsolateral 
and bilateral orbitofrontal cortices (contrary to what is normally observed in adults). 
Later in life, some compulsive disorders, such as OCD, are associated with 
age-related increases in ventral striatal volumes (Pujol et al. 2004; de Wit et al. 2014), 
and altered age-related neurodegeneration of the limbic brain areas (de Wit et al. 
2014), probably related to chronic compulsivity, anxiety and compensatory processes.  
Finally, with advancing age, specific alterations in the CSTC circuits seem to underlie 
compulsive behaviors in for instance frontotemporal dementia (Perry et al. 2012) and 
Parkinson’s disease (Vriend et al. 2014). 
 
During the whole lifespan the brain circuits remain plastic. The neuroplasticity of the 
brain is an entrance to therapeutic interventions. Since most literature on the 
relationship between treatment effects and changes in brain structure and function is 
based on studies in OCD, we here present a short summary of the findings so far in 
this disorder. 
 
a. Neuroplastic effects of cognitive behavioral therapy 
Cognitive-behavioral therapy (CBT), based mainly on exposure and response 
prevention, is the psychological treatment of choice for OCD and has demonstrated to 
be highly effective in reducing obsessive-compulsive and related symptoms. The 
analysis of CBT-related changes at the level of brain areas and circuits may contribute 
to the elucidation of neural mechanisms involved in the pathophysiology of the 
disorder as well as in its response to different therapeutic approaches. 
Although some studies failed to detect any significant structural change in 
response to CBT in pediatric and adult OCD patients (Rosenberg et al. 2000; Hoexter 
et al. 2012), others reported a volume increase of OFC gray matter (GM) and capsula 
externa white matter (WM) in children and adolescents with OCD after CBT (Huyser 
et al. 2013), maintained at two years follow-up (Huyser et al. 2014). A normalization 
of reduced GM and WM parietal volumes following combined pharmacological and 
CBT treatment has been also reported in pediatric OCD patients (Lázaro et al. 2009), 
suggesting some kind of structural plasticity in response to the modulatory effects of 
CBT. 
Initial positron emission tomography and single photon emission computed 
tomography studies in OCD reported a decrease in right caudate activity in CBT 
treatment responders, associated with the reduction of obsessive-compulsive symptom 
severity (Baxter et al. 1992; Schwartz et al. 1996; Nakatani et al. 2003), although 
conflicting findings have been also reported (Apostolova et al. 2010). Significant 
decreases in regional brain activity have also been described in prefrontal (both 
ventral and dorsal) cortices and thalamus (Nakatani et al. 2003; Saxena et al. 2009; 
Yamanishi et al. 2009), as well as increases in dorsal anterior cingulate cortex 
(Saxena et al. 2009) and posterior (occipital and parietal) regions (Yamanishi et al. 
2009). 
CBT-induced changes in task-related brain activation patterns have been 
analyzed for various dorsal and ventral cognitive control processes. For the Stroop 
task, results have been inconsistent as both increased (Nakao et al. 2005) and 
decreased (Nabeyama et al. 2008) prefrontal and temporal activation has been 
observed. Using a reversal learning task, Freyer et al. (2011) found, in OCD patients 
versus controls, decreased OFC and right putamen activation before treatment, and 
increased caudate nucleus activity in response to CBT. Since these findings were 
obtained at a lenient threshold only, these should be regarded as preliminary. In 
adolescent OCD patients, Huyser et al. (2010) demonstrated a significant decrease in 
reversal learning-related prefrontal activity in response to CBT. Changes in symptom 
severity correlated with changes in prefrontal and parietal activation patterns. The 
same authors (Huyser et al. 2011) reported increased anterior cingulate activation 
during error detection and increased bilateral insular activation during high-conflict 
trials, which was age-dependent and only partially affected by successful CBT. 
Overall, results of task-related changes in response to CBT suggest at least a partial 
normalization of pre-treatment differences between OCD patients and controls in 
response to CBT, but findings have been inconsistent and are in need of replication in 
larger samples. 
Studies in OCD investigating neural responses during symptom provocation 
before and after CBT are scarce. Using a pre-post design, Nakao et al. (2005) reported 
decreased activation in the putamen, cerebellum and orbitofrontal, anterior cingulate, 
insular, and temporal cortices during a symptom provocation task in a small sample of 
10 OCD patients, six of whom received CBT. Morigiève et al. (2014) recently 
corroborated these findings in a large-scale fMRI study, showing decreased responses 
to obsession-inducing images in the anterior cingulate and the orbitofrontal cortex in 
OCD patients treated with CBT.  
Studies using proton magnetic resonance spectroscopy to analyze changes on 
different brain biochemical compounds in response to CBT have likewise been 
scarce, and their results inconsistent. Both Benazon et al. (2003) and Zurowski et al. 
(2012) failed to detect any significant change on glutamatergic compounds and myo-
inositol concentration in response to CBT in OCD patients, although in the last study 
myo-inositol concentration in the OFC predicted the outcome to CBT. In contrast, 
O’Neill et al. (2012) reported a decrease of N-acetyl-aspartate (NAA) and creatinine 
concentrations in left pre-genual ACC and an increase of choline compounds in right 
thalamus in response to CBT in pediatric OCD patients that correlated with clinical 
improvement.  
Information on brain structure and function might be useful in the future to 
predict treatment response to CBT. Recent morphological studies have indicated that 
larger medial prefrontal volume (Hoexter et al., 2013) and thinner rostral cingulate 
cortex (Fullana et al., 2014) were associated with greater CBT-induced symptom 
reduction in OCD. In contrast, in fluoxetine-treated patients smaller pre-treatment 
dorsolateral prefrontal volume was associated with greater treatment response, 
suggesting that brain volume markers might be associated with specific interventions 
rather than with a non-specific general treatment response. Confirming Hoexter et 
al.’s results, Hashimoto et al. (2014) have recently reported smaller volumes of 
ventral prefrontal and anterior cingulate cortices in OCD non-responders to CBT. 
From a functional perspective, higher pre-treatment resting-state orbitofrontal activity 
was associated with a better response to CBT (Brody et al. 1998; Yamanishi et al. 
2009). In accordance with structural data, the opposite pattern was detected in a small 
group of patients treated with fluoxetine in whom lower orbitofrontal activity was 
associated with better response. Using a symptom provocation design, limbic activity 
was found to be correlated with OCD symptom reduction following CBT, whereas 
dorsal prefrontal activity prior to therapy was negatively associated with treatment 
response (Olatunji et al. 2013). Presumably, higher pre-treatment orbitofrontal 
metabolism may reflect a greater ability to change the assignment of affective value to 
stimuli and to be better able to extinguish habitual, compulsive responses, resulting in 
a better response to CBT. 
It has been proposed that the behavioral component of CBT, i.e., exposure-in 
vivo and response prevention, may reinstate goal-directed control on the maladaptive 
habitual behaviors stored in the basal ganglia (Gillan et al. 2011) and the extinction of 
the pathologically increased limbic response (Delgado et al. 2006). According to this 
hypothesis, reduction in caudate activity after CBT may reflect procedural learning to 
acquire new skills. On the other hand, the cognitive part of CBT, mainly involving 
reappraisal strategies to correct the erroneous cognitive patterns, is associated with 
increased activation of higher-order frontal regions involved in cognitive control of 
negative emotion (Clark & Beck 2010; Ochsner & Gross 2005). Hyperactivity of 
these areas during symptom exposure may underlie unsuccessful attempts to 
implement goal-directed action plans over compulsive habit-like rituals (Gillan et al., 
2011). Thus, successful CBT seems to rely on a combination of multiple changes 
within the various interacting CSTC and limbic circuits, involving enhanced 
effectiveness of the dorsal cognitive control circuit, increased recruitment of the 
ventromedial prefrontal cortex (as a key structure involved in extinction of 
conditioned responses), and reduction in the pathologically increased activation of 
both the sensorimotor CSTC circuit (associated with a reduction in habitual behavior) 
and the limbic areas (associated with a reduction in anxiety or distress).  
 
b. Neuroplastic effects of pharmacological interventions 
In addition to investigating the effects of CBT on regional brain morphology and 
function, a number of studies have investigated the effects of both acute 
pharmacological challenge and (sub)chronic treatment on brain circuitry function in 
healthy controls and patients with OCD (see Table 1). In healthy volunteers, serotonin 
manipulation studies have focused on the limbic system and emotional processing 
(Harmer & Cowen 2013) in view of the clinical use of selective serotonin re-uptake 
inhibitors (SSRIs) for their antidepressant and anxiolytic effects. Generally, SSRIs 
have been found to shift attention away from more negative or threatening aspects of 
the environment towards the more positive, and to dampen amygdala responses to 
emotional stimuli. In a meta-analysis of available single-dose studies, pooling results 
from different fMRI paradigms, SSRIs modulated activity in the amgydalo-
hippocampal formation, and mediofrontal cortices, during presentation of faces and 
pictures (Outhred et al. 2013). These findings were distinct from those reported with 
selective noradrenaline reuptake inhibitors, which tended to affect cortical regions 
alone. Subchronic and chronic (7-28 days) trials in healthy volunteers have also been 
undertaken. Escitalopram treatment versus placebo was associated with significant 
reductions in amygdala activation during an emotional face paradigm (Arce et al. 
2008) and low dose clomipramine or duloxetine treatments were associated with 
dampened neural responses to negatively valenced stimuli in the amygdala, anterior 
cingulate, and insula (de Almeida et al. 2010; van Marle et al. 2011). Duloxetine also 
affects the encoding and retrieval of such stimuli (Tendolkar et al. 2011). In resting-
state fMRI studies, citalopram versus placebo reduced the functional connectivity 
between the amygdala and the medial prefrontal cortex (McCabe et al. 2011a), and 
duloxetine reduced the functional connectivity of the default mode network and task-
positive network (van Wingen et al. 2014). Subchronic SSRI treatment seems to 
reduce reward processing in bilateral nucleus accumbens (erotic videos; Abler et al. 
2012) and ventral striatum/medial OFC (chocolate stimuli; McCabe et al. 2010), 
though subchronic duloxetine treatment increased ventral striatal responses during the 
anticipation of monetary rewards (Ossewaarde et al. 2011). Citalopram, and to a 
lesser degree the mixed reuptake inhibitor reboxetine, decreased activation in 
response to aversive stimuli (mouldly strawberries; MacCabe et al. 2010).  
In patients, predominantly in OCD, studies exploring the effects of SSRI 
intervention on brain function have employed both resting-state and activation 
designs. Using SPECT, fluvoxamine treatment (without a placebo arm) was found to 
be associated with reduced cerebral blood flow in the caudate nucleus and putamen, 
irrespective of treatment response. In contrast, treatment responders, but not non-
responders, exhibited treatment-associated reduced metabolism in the thalamus (Ho 
Pian et al. 2005). In a recent resting-state fMRI study in OCD, decreased pre-
treatment small-world neural efficiency tended to normalize following SSRI treatment, 
with symptom improvement correlating with changes in connectivity in the ventral 
frontal cortex (Shin et al. 2014). In pediatric OCD, brain activation during a serial 
reaction time task was measured before and after 6-month open-label naturalistic 
treatment with behavioural counseling and fluoxetine (Lazaro et al. 2008). OCD 
patients had higher activation in the middle frontal cortex compared to controls at 
baseline, whereas activation in the left insula and left putamen decreased over the 
course of treatment. Due to lack of a control arm and the dual nature of the 
intervention, it is difficult to infer which of these changes (if any) were due to SSRI. 
In an open-label non-controlled trial, using a spatial N-back task, working memory 
was found to improve in treatment responders, who showed a more linear relationship 
between brain activation and task difficulty, contrary to what was found in non-
responders (van der Wee et al. 2007).  
 In summary, SSRIs in healthy volunteers, given acutely or in sub-chronic 
dosing regimens, dampen neural responses in the amygdala and related limbic 
circuitry to anxiety-provoking and negative stimuli, and reduce functional coupling 
between relevant neural nodes. On the other hand, there is some evidence across 
studies that SSRI treatment in OCD led to reduced dorsal striatum (putamen/caudate) 
activity in the resting state. Findings from the few cognitive challenge studies were 
unclear, with methodological limitations (e.g. inclusion of multiple types of treatment, 
lack of an appropriate control condition). 
Antipsychotic medication increasingly used as an augmentation strategy for 
treatment resistant OCD, seem to modulate reward circuitry in healthy volunteers. A 
single dose of sulpiride versus placebo reduced activation in response to rewarding 
chocolate stimuli in the ventral striatum and anterior cingulate cortex, and also 
reduced orbitofrontal and insular activation in response to aversive stimuli (McCabe 
et al. 2011b). Using a monetary reward paradigm (Abler et al. 2007), a single dose 
olanzapine versus placebo dampened activation in the ventral striatum, anterior 
cingulate, and inferior frontal cortex. Risperidone treatment in OCD patients non-
responsive to ongoing SSRI treatment was associated with increased metabolism in 
the striatum, cingulate, prefrontal (especially orbital) cortex, and thalamus 
(Buchsbaum et al. 2006). Thus, dopamine antagonism dampens reward-related 
activation in the nucleus accumbens, and reduces activation in response to aversive 
stimuli in the insula/lateral OFC in healthy controls, while studies in OCD have 
generally not clearly addressed effects of this medication on emotional and reward 
processing. 
Regarding to brain structure, there is some mixed evidence that SSRI 
treatment is linked with increases in putamen volumes, and reductions of thalamic and 
amygdala volumes, and findings for white matter were also mostly inconsistent (see 
Table 2).  
To summarize, initial studies have indicated both similar and distinct brain 
changes in response to CBT and pharmacotherapy, suggesting both common and 
specific processes related to neuroplastic changes in response to treatment. Overall, 
caution is warranted with respect to interpreting the majority of OCD SSRI studies 
considered above, in view of frequent lack of placebo control or randomization, and 
the high possibility of practice effects and non-specific effects of time, and of indirect 
effects of reducing non-OCD symptoms such as depression. To help address such 
limitations, future research should include a variety of complementary measures 
within the same study (structural MRI, cortical morphology, DTI, resting state fMRI, 
fMRI disease-relevant cognitive challenge, and fMRI symptom provocation). Such 
work is likely to require large-scale international collaborations and input from 
traditionally disparate research fields. 
 
c. Neuroplastic effects of invasive and non-invasive neuromodulation 
In contrast to the more widespread effects of pharmacological treatments, 
neuromodulatory techniques may enable a more precise targeting of distinct neural 
circuits. Based on strong hypotheses on the underlying alterations in neural circuitries, 
OCRDs are particularly suitable for therapeutic modulation of these circuits.  
 Traditionally, neurosurgery was the only alternative option for severe OCD 
cases that were non-responding to CBT or pharmacological treatments. Based on a 
recent consensus guideline on neurosurgery in psychiatry (Nuttin et al. 2014), ablative 
procedures such as cingulotomy (Banks et al. 2014) and capsulotomy (Rück et al. 
2008) as well as the appealing (since less invasive) alternative methods, such as 
gamma-knife radiosurgery (Lopes et al. 2014) and deep brain stimulation (DBS) 
(Kisely et al. 2014) should be reserved for the small proportion of severely disabled 
treatment-resistant cases. Due to the still large proportion of treatment-resistant 
patients, in combination with the drawbacks of permanent lesioning the brain in case 
of ablative surgery, there is a strong need to invest in less permanent surgical 
procedures, such as DBS, and non-invasive alternatives, such as repetitive transcranial 
magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS). For a 
comprehensive overview of the effects of the various neuromodulatory approaches in 
OCD, see recent review papers (Jaafari et al. 2012; Kisely et al. 2014; Bais et al. 
2014; Lefaucheur et al. 2014). 
DBS consists of the implantation of two electrodes in specific brain areas of 
which stimulation parameters (e.g., frequency, pulse width, and intensity) are adjusted 
manually by a trained clinician. DBS is a unique tool to unravel the anatomical 
circuitry associated with the core symptoms of OCD such as compulsivity, because 
DBS may be switched on and off instantly in a double-blind fashion, and may be used 
to record local field potentials from brain regions directly associated with symptom 
changes. In the past decade, DBS has been applied in over 200 patients worldwide 
using two different targets, the ventral striatal area and the nucleus subthalamicus. 
Some will remark that more targets have been explored, but often just the names 
differ and not the target itself. The ventral capsule, the (ventral part) of the anterior 
limb of the capsula interna, and the nucleus accumbens, all share a similar positioning 
on the x and z-plane but slightly differ in anterior-posterior positioning on the y-
plane. What have we learned from DBS enabling us to understand better the circuitry 
of compulsivity? First, even though DBS is targeted at one single brain area, its 
therapeutic effect appears to be due to the modulation of a network, since effects of 
DBS have been measured in remote brain areas. Figee et al. (2013) showed that DBS 
targeted at the nucleus accumbens in OCD patients normalized nucleus accumbens 
activation but as well reduced the pre-treatment increased connectivity between the 
accumbens and the prefrontal cortex. This reduction in over-connectivity correlates 
with symptom improvements, empirically supporting the hypothesis that DBS 
overwrites pathologic network activity. A glucose (PET) study showed a decrease in 
prefrontal cortex metabolism following DBS of the subthalamic nucleus (Lejeune 
2010). Second, modulation of the circuitry results in rapid symptom changes. These 
changes may be due to alterations in the synchronization dynamics within the fronto-
striatal network. Smolders et al (2013) have shown that DBS may reduce the phase 
stability of frontal theta oscillations without affecting theta power. A similar finding 
has been reported with DBS of the subthalamic nucleus (Bastin 2014). Third, Figee et 
al. (2014) showed that DBS of the nucleus accumbens induced striatal dopamine 
release, associated with improved clinical status, suggesting that DBS may 
compensate for a defective dopaminergic system.  
The most obvious difference between invasive neuromodulation by DBS and 
the non-invasive modulation by rTMS or tDCS, is the primary focus of stimulation. In 
DBS the subcortical CSTC regions (e.g., the anterior limb of the capsula interna, the 
ventral capsule/striatum, and the nucleus accumbens) are stimulated, aiming at 
inhibiting the hyperactivated ventral motivational CSTC circuit. Using rTMS or 
tDCS, the cortical CSTC regions are targeted, aiming at enhancing the function of the 
dorsal cognitive CSTC circuit (when targeting the dorsolateral prefrontal cortex) or 
inhibiting the sensorimotor CSTC circuit (by stimulation of the supplementary motor 
area). In rats DBS in the ventral striatum reduced fear expression and strengthened 
extinction memory (Rodriquez-Romaguera et al. 2012). Recent work on left 
dorsolateral prefrontal rTMS versus sham showed that rTMS may modulate automatic 
emotion regulation capacity by influencing fronto-limbic connectivity (de Wit et al. 
2015). In a recent paper on a broad range of psychiatric and neurological disorders, 
Fox et al. (2014) showed that invasive (e.g., DBS) and non-invasive (e.g., rTMS and 
tDCS) techniques for neurostimulation, although using different targets for 
stimulation, in fact target different nodes within the same network. This opens new 
opportunities to translate knowledge from mechanistic research in DBS to targets for 
non-invasive neuromodulatory therapies, in this way enabling a partial shift from 
expensive invasive neurosurgical interventions to cheaper non-invasive treatments in 
the future (van den Heuvel et al. 2015). The other important difference between DBS 
and rTMS is the continuous stimulation in DBS versus the temporal stimulation in 
rTMS or tDCS. Although also in rTMS/tDCS long-lasting effects can be achieved, via 
long-term potentiation and long-term depression of specific CSTC connections, these 
techniques should be regarded as adjuvant techniques aiming at the potentiation of the 
behavioral changes trained during CBT, by enhancing the extinction of conditioned 
responses, reducing the over-reliance on habitual behaviors, or by improving emotion 
regulation strategies. In this way it can function as catalyst of a behavioral change. 
Also for DBS rules that optimal treatment effects are achieved in case of adjuvant 
CBT (Mantione et al. 2014). 
 
Conclusions and future directions 
As illustrated by this overview the brain circuits involved in compulsivity are 
plastic, and the findings of neuroimaging studies largely depend on the 
developmental stage of the subjects included, the stage of disease and presence of 
chronicity, the actual mental state during data acquisition related to the study 
design and the condition of the patients, and the effects of experienced past and 
current treatments.  
Since most research used strict age ranges, a gap exists between paediatric 
and adult studies. Heterogeneity within the disease group is large, due to variation 
in symptom profile, neurodevelopmental stage, disease stage, and treatment 
history. Since symptoms often start in childhood and progress towards adulthood, 
in adult studies it is impossible to disentangle the neural correlates implicated in 
cause and consequence of the disease. Therefore, a lifespan approach is needed to 
understand how brain changes relate to profile and stage. Insight in the pre-
symptomatic stage of the disease, before the brain has been changed by the disease 
and treatments, will help to understand how risk confers to disease. The extreme 
opposite end of the longitudinal design is post-mortem research of the brain from 
ante-mortem well-characterized patients, including ante- and post-mortem brain 
imaging. This enables the translation from cellular findings to in vivo-brain 
imaging characteristics and clinical phenotypes, and stimulates the development of 
treatment modalities that directly target the underlying cellular mechanisms. 
Most literature is based on studies in a mono-diagnostic group of patients 
versus controls, hampering the study on overlap and differentiation across related 
disorders. Trans-diagnostic studies need to be a priority. Brain imaging communities 
in different diseases increasingly start collaborating, aiming to perform meta- and 
mega-analyses and trans-diagnostic comparisons. A good example is ENIGMA 
(Enhancing NeuroImaging and Genetics by Meta-Analysis), an unprecedented 
initiative to pool MRI and genetic data of the major mental disorders, to perform 
imaging-genetics meta-analyses (Thompson et al. 2014). The overall goal is to unite 
the imaging and genomics communities to solve biomedical problems that no one 
group could answer alone, by performing well-powered trans-diagnostic comparisons 
and by studying general mechanism related to altered brain development across the 
life span, and under influence of genetic (both risk and protecting factors) and 
environmental factors (e.g., medication).  
The field may benefit from better translation from fundamental studies on 
brain circuit structure and function to targets for innovative treatments as well as 
brain-based guidance of clinical practice. After 3 decades of brain imaging research 
trying to understand disease mechanism at the group level, the field now needs the 
shift toward prediction of treatment response and disease course prospectively at the 
individual level. The machine learning approach might help to achieve this goal (Orrù 
et al. 2015), but so far studies have been small, mainly in depression, and these 
studies achieved only moderate classification accuracies. Increased classification 
might be reached by the combined analyses of both clinical characteristics related to 
disease profile and disease stage, and information from multi-modal brain imaging 
measurements. However, from a practical and cost-efficiency point of view, 
widespread use of neuroimaging-based prediction markers of treatment response, in 
case of proven feasibility, necessitates a shift to cheaper and more widely available 
imaging techniques, such as electroencephalography (EEG), to implement in the 
clinical setting (van den Heuvel, 2015). 
 
Figure: 
Title: For compulsivity relevant cortico-striato-thalamo-cortical (CSTC) and fronto-
limbic circuits 
Abbreviations: 
SMA: supplementary motor area, preSMA: pre-supplementary motor area, dmPFC: 
dorsomedial prefrontal cortex, IFG: inferior frontal gyrus, vlPFC: ventrolateral 
prefrontal cortex, OFC: orbitofrontal cortex, vmPFC: ventromedial prefrontal cortex, 
pPut: posterior putamen, dCaud: dorsal caudate nucleus, vCaud: ventral caudate 
nucleus, NAcc: nucleus accumbens, Amygd: amygdala, Tham: thalamus, CSTC: 
cortico-striato-thalamo-cortical.  
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